IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build 150

IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions

: IDEA4RC Vocabulary Code System - XML Representation

Draft as of 2025-09-10

Raw xml | Download


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="cs-idea4rc-vocab-eu-i4rc"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem cs-idea4rc-vocab-eu-i4rc</b></p><a name="cs-idea4rc-vocab-eu-i4rc"> </a><a name="hccs-idea4rc-vocab-eu-i4rc"> </a><p>This case-sensitive code system <code>http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">2000100001<a name="cs-idea4rc-vocab-eu-i4rc-2000100001"> </a></td><td>IDEA4RC_vocab</td></tr><tr><td style="white-space:nowrap">2000100002<a name="cs-idea4rc-vocab-eu-i4rc-2000100002"> </a></td><td>Recurrence</td></tr><tr><td style="white-space:nowrap">2000100003<a name="cs-idea4rc-vocab-eu-i4rc-2000100003"> </a></td><td>Radiation-induced sarcoma</td></tr><tr><td style="white-space:nowrap">2000100004<a name="cs-idea4rc-vocab-eu-i4rc-2000100004"> </a></td><td>HPV-related Multiphenotypic Sinonasal Carcinoma</td></tr><tr><td style="white-space:nowrap">2000100005<a name="cs-idea4rc-vocab-eu-i4rc-2000100005"> </a></td><td>So-called fibrohistiocytic tumours</td></tr><tr><td style="white-space:nowrap">2000100006<a name="cs-idea4rc-vocab-eu-i4rc-2000100006"> </a></td><td>Vascular tumours</td></tr><tr><td style="white-space:nowrap">2000100007<a name="cs-idea4rc-vocab-eu-i4rc-2000100007"> </a></td><td>Pericytic (perivascular) tumours</td></tr><tr><td style="white-space:nowrap">2000100008<a name="cs-idea4rc-vocab-eu-i4rc-2000100008"> </a></td><td>Undifferentiated small round cell sarcomas of bone and soft tissue</td></tr><tr><td style="white-space:nowrap">2000100009<a name="cs-idea4rc-vocab-eu-i4rc-2000100009"> </a></td><td>Endometrial stromal sarcoma</td></tr><tr><td style="white-space:nowrap">2000100010<a name="cs-idea4rc-vocab-eu-i4rc-2000100010"> </a></td><td>Miscellanious mesenchimal tumors</td></tr><tr><td style="white-space:nowrap">2000100011<a name="cs-idea4rc-vocab-eu-i4rc-2000100011"> </a></td><td>Mixed epithelial and mesenchymal tumours</td></tr><tr><td style="white-space:nowrap">2000100012<a name="cs-idea4rc-vocab-eu-i4rc-2000100012"> </a></td><td>Non-keratinizing squamous cell carcinoma: SMARCB1 (INI-1)-deficient Sinonasal Carcinoma</td></tr><tr><td style="white-space:nowrap">2000100013<a name="cs-idea4rc-vocab-eu-i4rc-2000100013"> </a></td><td>Non-keratinizing squamous cell carcinoma: Transitional (cylindrical cell, Schneiderian) carcinoma</td></tr><tr><td style="white-space:nowrap">2000100014<a name="cs-idea4rc-vocab-eu-i4rc-2000100014"> </a></td><td>Spindle cell (sarcomatoid) squamous cell carcinoma: SMARCB1 (INI-1)</td></tr><tr><td style="white-space:nowrap">2000100015<a name="cs-idea4rc-vocab-eu-i4rc-2000100015"> </a></td><td>SMARCB1 (INI-1)-deficient Sinonasal undifferentiated Carcinoma</td></tr><tr><td style="white-space:nowrap">2000100016<a name="cs-idea4rc-vocab-eu-i4rc-2000100016"> </a></td><td>Sinonasal SMARCA4 deficient carcinoma</td></tr><tr><td style="white-space:nowrap">2000100017<a name="cs-idea4rc-vocab-eu-i4rc-2000100017"> </a></td><td>IDH2-mutated sinonasal undifferentiated neoplasm</td></tr><tr><td style="white-space:nowrap">2000100018<a name="cs-idea4rc-vocab-eu-i4rc-2000100018"> </a></td><td>HPV-related Multiphenotypic Sinonasal Carcinoma</td></tr><tr><td style="white-space:nowrap">2000100019<a name="cs-idea4rc-vocab-eu-i4rc-2000100019"> </a></td><td>NTRK-rearranged spindle cell neoplasm (emerging)</td></tr><tr><td style="white-space:nowrap">2000100020<a name="cs-idea4rc-vocab-eu-i4rc-2000100020"> </a></td><td>Middle Ear</td></tr><tr><td style="white-space:nowrap">2000100021<a name="cs-idea4rc-vocab-eu-i4rc-2000100021"> </a></td><td>Oral cavity</td></tr><tr><td style="white-space:nowrap">2000100022<a name="cs-idea4rc-vocab-eu-i4rc-2000100022"> </a></td><td>Periscapular</td></tr><tr><td style="white-space:nowrap">2000100023<a name="cs-idea4rc-vocab-eu-i4rc-2000100023"> </a></td><td>Groin Flap</td></tr><tr><td style="white-space:nowrap">2000100024<a name="cs-idea4rc-vocab-eu-i4rc-2000100024"> </a></td><td>Anterior 2/3 of tongue NOS</td></tr><tr><td style="white-space:nowrap">2000100025<a name="cs-idea4rc-vocab-eu-i4rc-2000100025"> </a></td><td>Fluorodeoxyglucose positron emission tomography</td></tr><tr><td style="white-space:nowrap">2000100026<a name="cs-idea4rc-vocab-eu-i4rc-2000100026"> </a></td><td>Positron emission tomography using other tracers</td></tr><tr><td style="white-space:nowrap">2000100027<a name="cs-idea4rc-vocab-eu-i4rc-2000100027"> </a></td><td>Combined surgical approach</td></tr><tr><td style="white-space:nowrap">2000100028<a name="cs-idea4rc-vocab-eu-i4rc-2000100028"> </a></td><td>Concomitant Systemic Treatment</td></tr><tr><td style="white-space:nowrap">2000100029<a name="cs-idea4rc-vocab-eu-i4rc-2000100029"> </a></td><td>Systemic treatment alone</td></tr><tr><td style="white-space:nowrap">2000100030<a name="cs-idea4rc-vocab-eu-i4rc-2000100030"> </a></td><td>Treatment ended due to comorbidity</td></tr><tr><td style="white-space:nowrap">2000100031<a name="cs-idea4rc-vocab-eu-i4rc-2000100031"> </a></td><td>Preoperative radiotherapy concomitant to systemic treatment</td></tr><tr><td style="white-space:nowrap">2000100032<a name="cs-idea4rc-vocab-eu-i4rc-2000100032"> </a></td><td>Postoperative radiotherapy concomitant to systemic treatment</td></tr><tr><td style="white-space:nowrap">2000100033<a name="cs-idea4rc-vocab-eu-i4rc-2000100033"> </a></td><td>Definitive radiotherapy</td></tr><tr><td style="white-space:nowrap">2000100034<a name="cs-idea4rc-vocab-eu-i4rc-2000100034"> </a></td><td>Definitive radiotherapy concomitant to systemic treatment</td></tr><tr><td style="white-space:nowrap">2000100035<a name="cs-idea4rc-vocab-eu-i4rc-2000100035"> </a></td><td>Two dimensional (2D) radiotherapy</td></tr><tr><td style="white-space:nowrap">2000100036<a name="cs-idea4rc-vocab-eu-i4rc-2000100036"> </a></td><td>Three dimensional (3D) radiotherapy</td></tr><tr><td style="white-space:nowrap">2000100037<a name="cs-idea4rc-vocab-eu-i4rc-2000100037"> </a></td><td>Intensity modulated radiation therapy (IMRT)</td></tr><tr><td style="white-space:nowrap">2000100038<a name="cs-idea4rc-vocab-eu-i4rc-2000100038"> </a></td><td>Volumetric modulated arc therapy (VMAT)</td></tr><tr><td style="white-space:nowrap">2000100039<a name="cs-idea4rc-vocab-eu-i4rc-2000100039"> </a></td><td>Tomotherapy</td></tr><tr><td style="white-space:nowrap">2000100040<a name="cs-idea4rc-vocab-eu-i4rc-2000100040"> </a></td><td>Stereotactic radiotherapy (SBRT)</td></tr><tr><td style="white-space:nowrap">2000100041<a name="cs-idea4rc-vocab-eu-i4rc-2000100041"> </a></td><td>Ultra high dose rate radiotherapy (Flash therapy)</td></tr><tr><td style="white-space:nowrap">2000100042<a name="cs-idea4rc-vocab-eu-i4rc-2000100042"> </a></td><td>Passive scattering</td></tr><tr><td style="white-space:nowrap">2000100043<a name="cs-idea4rc-vocab-eu-i4rc-2000100043"> </a></td><td>Single beam optimization</td></tr><tr><td style="white-space:nowrap">2000100044<a name="cs-idea4rc-vocab-eu-i4rc-2000100044"> </a></td><td>Intensity modulated proton therapy (IMPT)</td></tr><tr><td style="white-space:nowrap">2000100045<a name="cs-idea4rc-vocab-eu-i4rc-2000100045"> </a></td><td>Adaptive radiotherapy</td></tr><tr><td style="white-space:nowrap">2000100046<a name="cs-idea4rc-vocab-eu-i4rc-2000100046"> </a></td><td>Image guided radiotherapy (IGRT)</td></tr><tr><td style="white-space:nowrap">2000100047<a name="cs-idea4rc-vocab-eu-i4rc-2000100047"> </a></td><td>Re-irradiation in field of first radiation</td></tr><tr><td style="white-space:nowrap">2000100048<a name="cs-idea4rc-vocab-eu-i4rc-2000100048"> </a></td><td>Re-irradiation out of field of first radiation</td></tr><tr><td style="white-space:nowrap">2000100049<a name="cs-idea4rc-vocab-eu-i4rc-2000100049"> </a></td><td>Re-irradiation marginal field of first radiation</td></tr><tr><td style="white-space:nowrap">2000100050<a name="cs-idea4rc-vocab-eu-i4rc-2000100050"> </a></td><td>Less than one week</td></tr><tr><td style="white-space:nowrap">2000100051<a name="cs-idea4rc-vocab-eu-i4rc-2000100051"> </a></td><td>More than one week but less than a month</td></tr><tr><td style="white-space:nowrap">2000100052<a name="cs-idea4rc-vocab-eu-i4rc-2000100052"> </a></td><td>More than a month but less than 3 months</td></tr><tr><td style="white-space:nowrap">2000100053<a name="cs-idea4rc-vocab-eu-i4rc-2000100053"> </a></td><td>More than 3 months</td></tr><tr><td style="white-space:nowrap">2000100054<a name="cs-idea4rc-vocab-eu-i4rc-2000100054"> </a></td><td>doxorubicin and vincristine </td></tr><tr><td style="white-space:nowrap">2000100055<a name="cs-idea4rc-vocab-eu-i4rc-2000100055"> </a></td><td>gemcitabine and vincristine</td></tr><tr><td style="white-space:nowrap">2000100056<a name="cs-idea4rc-vocab-eu-i4rc-2000100056"> </a></td><td>high dose cisplatin</td></tr><tr><td style="white-space:nowrap">2000100057<a name="cs-idea4rc-vocab-eu-i4rc-2000100057"> </a></td><td>ifosfamide and etoposide</td></tr><tr><td style="white-space:nowrap">2000100058<a name="cs-idea4rc-vocab-eu-i4rc-2000100058"> </a></td><td>weekly carboplatin</td></tr><tr><td style="white-space:nowrap">2000100059<a name="cs-idea4rc-vocab-eu-i4rc-2000100059"> </a></td><td>weekly cisplatin</td></tr><tr><td style="white-space:nowrap">2000100060<a name="cs-idea4rc-vocab-eu-i4rc-2000100060"> </a></td><td>Vincristine and Doxorubicin and Ifosfamide</td></tr><tr><td style="white-space:nowrap">2000100061<a name="cs-idea4rc-vocab-eu-i4rc-2000100061"> </a></td><td>Methotrexate and Doxorubicin and Cisplatin</td></tr><tr><td style="white-space:nowrap">2000100062<a name="cs-idea4rc-vocab-eu-i4rc-2000100062"> </a></td><td>Methotrexate and Doxorubicin and Ifosfamide</td></tr><tr><td style="white-space:nowrap">2000100063<a name="cs-idea4rc-vocab-eu-i4rc-2000100063"> </a></td><td>Doxorubicin and Cisplatin and Ifosfamide</td></tr><tr><td style="white-space:nowrap">2000100064<a name="cs-idea4rc-vocab-eu-i4rc-2000100064"> </a></td><td>Methotrexate and Vinorelbine</td></tr><tr><td style="white-space:nowrap">2000100065<a name="cs-idea4rc-vocab-eu-i4rc-2000100065"> </a></td><td>Vincristine and Doxorubicin and Cyclophosphamide</td></tr><tr><td style="white-space:nowrap">2000100066<a name="cs-idea4rc-vocab-eu-i4rc-2000100066"> </a></td><td>Doxorubicin and Ifosfamide and Dacarbazine</td></tr><tr><td style="white-space:nowrap">2000100067<a name="cs-idea4rc-vocab-eu-i4rc-2000100067"> </a></td><td>Irinotecan and Vincristine</td></tr><tr><td style="white-space:nowrap">2000100068<a name="cs-idea4rc-vocab-eu-i4rc-2000100068"> </a></td><td>TNF and Melphalan</td></tr><tr><td style="white-space:nowrap">2000100069<a name="cs-idea4rc-vocab-eu-i4rc-2000100069"> </a></td><td>Cyclophosphamide and Vinorelbine</td></tr><tr><td style="white-space:nowrap">2000100070<a name="cs-idea4rc-vocab-eu-i4rc-2000100070"> </a></td><td>high dose Ifosfamide</td></tr><tr><td style="white-space:nowrap">2000100071<a name="cs-idea4rc-vocab-eu-i4rc-2000100071"> </a></td><td>Alive, No Evidence of Disease (NED)</td></tr><tr><td style="white-space:nowrap">2000100072<a name="cs-idea4rc-vocab-eu-i4rc-2000100072"> </a></td><td>Dead of Disease (DOD)</td></tr><tr><td style="white-space:nowrap">2000100073<a name="cs-idea4rc-vocab-eu-i4rc-2000100073"> </a></td><td>Dead of Other Cause (DOC)</td></tr><tr><td style="white-space:nowrap">2000100074<a name="cs-idea4rc-vocab-eu-i4rc-2000100074"> </a></td><td>Dead of Unknown Cause (DUC)</td></tr><tr><td style="white-space:nowrap">2000100075<a name="cs-idea4rc-vocab-eu-i4rc-2000100075"> </a></td><td>Alive With Disease (AWD)</td></tr></table></div>
  </text>
  <url
       value="http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc"/>
  <version value="0.1.0"/>
  <name value="CsIdea4rcVocab"/>
  <title value="IDEA4RC Vocabulary Code System"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2025-09-10T15:18:34+00:00"/>
  <publisher value="IDEA4RC Project"/>
  <contact>
    <name value="IDEA4RC Project"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.idea4rc.eu/"/>
    </telecom>
  </contact>
  <contact>
    <name value="IDEA4RC Project"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.idea4rc.eu/"/>
    </telecom>
  </contact>
  <description
               value="Temporary coded concepts to be used by this Project waiting for the assignement from international terminologies."/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="150"/>
      <display value="Europe"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="75"/>
  <concept>
    <code value="2000100001"/>
    <display value="IDEA4RC_vocab"/>
  </concept>
  <concept>
    <code value="2000100002"/>
    <display value="Recurrence"/>
  </concept>
  <concept>
    <code value="2000100003"/>
    <display value="Radiation-induced sarcoma"/>
  </concept>
  <concept>
    <code value="2000100004"/>
    <display value="HPV-related Multiphenotypic Sinonasal Carcinoma"/>
  </concept>
  <concept>
    <code value="2000100005"/>
    <display value="So-called fibrohistiocytic tumours"/>
  </concept>
  <concept>
    <code value="2000100006"/>
    <display value="Vascular tumours"/>
  </concept>
  <concept>
    <code value="2000100007"/>
    <display value="Pericytic (perivascular) tumours"/>
  </concept>
  <concept>
    <code value="2000100008"/>
    <display
             value="Undifferentiated small round cell sarcomas of bone and soft tissue"/>
  </concept>
  <concept>
    <code value="2000100009"/>
    <display value="Endometrial stromal sarcoma"/>
  </concept>
  <concept>
    <code value="2000100010"/>
    <display value="Miscellanious mesenchimal tumors"/>
  </concept>
  <concept>
    <code value="2000100011"/>
    <display value="Mixed epithelial and mesenchymal tumours"/>
  </concept>
  <concept>
    <code value="2000100012"/>
    <display
             value="Non-keratinizing squamous cell carcinoma: SMARCB1 (INI-1)-deficient Sinonasal Carcinoma"/>
  </concept>
  <concept>
    <code value="2000100013"/>
    <display
             value="Non-keratinizing squamous cell carcinoma: Transitional (cylindrical cell, Schneiderian) carcinoma"/>
  </concept>
  <concept>
    <code value="2000100014"/>
    <display
             value="Spindle cell (sarcomatoid) squamous cell carcinoma: SMARCB1 (INI-1)"/>
  </concept>
  <concept>
    <code value="2000100015"/>
    <display
             value="SMARCB1 (INI-1)-deficient Sinonasal undifferentiated Carcinoma"/>
  </concept>
  <concept>
    <code value="2000100016"/>
    <display value="Sinonasal SMARCA4 deficient carcinoma"/>
  </concept>
  <concept>
    <code value="2000100017"/>
    <display value="IDH2-mutated sinonasal undifferentiated neoplasm"/>
  </concept>
  <concept>
    <code value="2000100018"/>
    <display value="HPV-related Multiphenotypic Sinonasal Carcinoma"/>
  </concept>
  <concept>
    <code value="2000100019"/>
    <display value="NTRK-rearranged spindle cell neoplasm (emerging)"/>
  </concept>
  <concept>
    <code value="2000100020"/>
    <display value="Middle Ear"/>
  </concept>
  <concept>
    <code value="2000100021"/>
    <display value="Oral cavity"/>
  </concept>
  <concept>
    <code value="2000100022"/>
    <display value="Periscapular"/>
  </concept>
  <concept>
    <code value="2000100023"/>
    <display value="Groin Flap"/>
  </concept>
  <concept>
    <code value="2000100024"/>
    <display value="Anterior 2/3 of tongue NOS"/>
  </concept>
  <concept>
    <code value="2000100025"/>
    <display value="Fluorodeoxyglucose positron emission tomography"/>
  </concept>
  <concept>
    <code value="2000100026"/>
    <display value="Positron emission tomography using other tracers"/>
  </concept>
  <concept>
    <code value="2000100027"/>
    <display value="Combined surgical approach"/>
  </concept>
  <concept>
    <code value="2000100028"/>
    <display value="Concomitant Systemic Treatment"/>
  </concept>
  <concept>
    <code value="2000100029"/>
    <display value="Systemic treatment alone"/>
  </concept>
  <concept>
    <code value="2000100030"/>
    <display value="Treatment ended due to comorbidity"/>
  </concept>
  <concept>
    <code value="2000100031"/>
    <display
             value="Preoperative radiotherapy concomitant to systemic treatment"/>
  </concept>
  <concept>
    <code value="2000100032"/>
    <display
             value="Postoperative radiotherapy concomitant to systemic treatment"/>
  </concept>
  <concept>
    <code value="2000100033"/>
    <display value="Definitive radiotherapy"/>
  </concept>
  <concept>
    <code value="2000100034"/>
    <display
             value="Definitive radiotherapy concomitant to systemic treatment"/>
  </concept>
  <concept>
    <code value="2000100035"/>
    <display value="Two dimensional (2D) radiotherapy"/>
  </concept>
  <concept>
    <code value="2000100036"/>
    <display value="Three dimensional (3D) radiotherapy"/>
  </concept>
  <concept>
    <code value="2000100037"/>
    <display value="Intensity modulated radiation therapy (IMRT)"/>
  </concept>
  <concept>
    <code value="2000100038"/>
    <display value="Volumetric modulated arc therapy (VMAT)"/>
  </concept>
  <concept>
    <code value="2000100039"/>
    <display value="Tomotherapy"/>
  </concept>
  <concept>
    <code value="2000100040"/>
    <display value="Stereotactic radiotherapy (SBRT)"/>
  </concept>
  <concept>
    <code value="2000100041"/>
    <display value="Ultra high dose rate radiotherapy (Flash therapy)"/>
  </concept>
  <concept>
    <code value="2000100042"/>
    <display value="Passive scattering"/>
  </concept>
  <concept>
    <code value="2000100043"/>
    <display value="Single beam optimization"/>
  </concept>
  <concept>
    <code value="2000100044"/>
    <display value="Intensity modulated proton therapy (IMPT)"/>
  </concept>
  <concept>
    <code value="2000100045"/>
    <display value="Adaptive radiotherapy"/>
  </concept>
  <concept>
    <code value="2000100046"/>
    <display value="Image guided radiotherapy (IGRT)"/>
  </concept>
  <concept>
    <code value="2000100047"/>
    <display value="Re-irradiation in field of first radiation"/>
  </concept>
  <concept>
    <code value="2000100048"/>
    <display value="Re-irradiation out of field of first radiation"/>
  </concept>
  <concept>
    <code value="2000100049"/>
    <display value="Re-irradiation marginal field of first radiation"/>
  </concept>
  <concept>
    <code value="2000100050"/>
    <display value="Less than one week"/>
  </concept>
  <concept>
    <code value="2000100051"/>
    <display value="More than one week but less than a month"/>
  </concept>
  <concept>
    <code value="2000100052"/>
    <display value="More than a month but less than 3 months"/>
  </concept>
  <concept>
    <code value="2000100053"/>
    <display value="More than 3 months"/>
  </concept>
  <concept>
    <code value="2000100054"/>
    <display value="doxorubicin and vincristine "/>
  </concept>
  <concept>
    <code value="2000100055"/>
    <display value="gemcitabine and vincristine"/>
  </concept>
  <concept>
    <code value="2000100056"/>
    <display value="high dose cisplatin"/>
  </concept>
  <concept>
    <code value="2000100057"/>
    <display value="ifosfamide and etoposide"/>
  </concept>
  <concept>
    <code value="2000100058"/>
    <display value="weekly carboplatin"/>
  </concept>
  <concept>
    <code value="2000100059"/>
    <display value="weekly cisplatin"/>
  </concept>
  <concept>
    <code value="2000100060"/>
    <display value="Vincristine and Doxorubicin and Ifosfamide"/>
  </concept>
  <concept>
    <code value="2000100061"/>
    <display value="Methotrexate and Doxorubicin and Cisplatin"/>
  </concept>
  <concept>
    <code value="2000100062"/>
    <display value="Methotrexate and Doxorubicin and Ifosfamide"/>
  </concept>
  <concept>
    <code value="2000100063"/>
    <display value="Doxorubicin and Cisplatin and Ifosfamide"/>
  </concept>
  <concept>
    <code value="2000100064"/>
    <display value="Methotrexate and Vinorelbine"/>
  </concept>
  <concept>
    <code value="2000100065"/>
    <display value="Vincristine and Doxorubicin and Cyclophosphamide"/>
  </concept>
  <concept>
    <code value="2000100066"/>
    <display value="Doxorubicin and Ifosfamide and Dacarbazine"/>
  </concept>
  <concept>
    <code value="2000100067"/>
    <display value="Irinotecan and Vincristine"/>
  </concept>
  <concept>
    <code value="2000100068"/>
    <display value="TNF and Melphalan"/>
  </concept>
  <concept>
    <code value="2000100069"/>
    <display value="Cyclophosphamide and Vinorelbine"/>
  </concept>
  <concept>
    <code value="2000100070"/>
    <display value="high dose Ifosfamide"/>
  </concept>
  <concept>
    <code value="2000100071"/>
    <display value="Alive, No Evidence of Disease (NED)"/>
  </concept>
  <concept>
    <code value="2000100072"/>
    <display value="Dead of Disease (DOD)"/>
  </concept>
  <concept>
    <code value="2000100073"/>
    <display value="Dead of Other Cause (DOC)"/>
  </concept>
  <concept>
    <code value="2000100074"/>
    <display value="Dead of Unknown Cause (DUC)"/>
  </concept>
  <concept>
    <code value="2000100075"/>
    <display value="Alive With Disease (AWD)"/>
  </concept>
</CodeSystem>